Article

Serum metabolic signatures for Alzheimer’s Disease reveal alterations in amino acid composition and energy metabolism – A validation study

2023-04-05

Abstract excerpt

<h4>Background: </h4> Alzheimer’s Disease (AD) is complex and novel approaches are urgently needed to characterise disease pathology and to aid in diagnosis. Metabolites are the end-products of upstream molecular alterations, whereby small changes at the genetic or protein level result in substantial changes at the metabolite level. Blood is frequently used as a source for biomarkers; however, its complexity preve...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4669b39d-ab95-59f8-a0fe-14f7013c8cef
DOI: 10.21203/rs.3.rs-2765583/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Serum metabolic signatures for Alzheimer’s Disease reveal alterations in amino acid composition and energy metabolism – A validation studyDOI 10.21203/rs.3.rs-2765583/v1Read

Serum metabolic signatures for Alzheimer’s Disease reveal alterations in amino acid composition: a validation studySemantic proximity Read

Differences in Plasma Metabolites Related to Alzheimer’s Disease, APOE-ε4 status and EthnicitySemantic proximity Read

Alteration of Metabolic Profile During the Progression of Alzheimer’s DiseaseSemantic proximity Read

Large-scale proteome and metabolome analysis of CSF implicates altered glucose metabolism and succinylcarnitine in Alzheimer’s diseaseSemantic proximity Read

Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohortSemantic proximity Read

Circulating Metabolites are Linked to Dementia and Brain Imaging Phenotypes, and Mediate Modifiable Risk PathwaysSemantic proximity Read

CSF metabolites associated with biomarkers of Alzheimer’s disease pathologySemantic proximity Read

Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer’s diseaseSemantic proximity Read

Integrating large-scale serum metabolomics and <i>APOE</i> ε4 genotype status for the non-invasive detection of Alzheimer’s disease in the ADNI cohortSemantic proximity Read

Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohortSemantic proximity Read

Predictive Modeling of Alzheimer's and Parkinson's Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal FluidSemantic proximity Read

Metabolomic changes associated with frontotemporal lobar degeneration syndromesSemantic proximity Read